Managing passengers with respiratory disease planning air travel: British Thoracic Society recommendations

1. Iglesias R., Cortes M.D.C.G., Almanza C. Facing air passengers' medical problems while on board. Aerospace Med. 1974; 45: 204–206.

2. http://www.medaire.com. February 2001.

3. Coker R.K., Partridge M.R. Assessing the risk for hypoxia in flight: the need for more rational guidelines. Eur. Respir. J. 2000; 15: 128–130.

4. COPD Guidelines Group of the Standards of Care Committee of the British Thoracic Society. BTS guidelines for the management of chronic obstructive pulmonary disease. Thorax 1997; 52 (suppl. 5): S1–28.

5. Siafakas N.M., Vermeire P., Pride N.B. et al. Optimal assessment and management of chronic obstructive pulmonary disease (COPD). Eur. Respir. J. 1995; 8: 1398–1420.

6. Royal College of Physicians. Domiciliary oxygen prescribing services. Clinical guidelines and advice for prescribers. London: Royal College of Physicians, 1999.

7. American Thoracic Society. ATS statement: standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 1995;.152: S77–120.

8. Lien D., Turner M.D. Recommendations for patients with chronic respiratory disease considering air travel: a statement from the Canadian Thoracic Society. Can. Respir. J. 1998; 5: 95–100.

9. Ernsting J., Nicholson A.N., Rainford D.J. Aviation medicine. 3rd ed. Oxford: Butterworth Heinmann, 1999.

10. Aerospace Medical Association. Medical guidelines for air travel. Aviat. Space Environ. Med. 1996; 67 (10 suppl.): B1–16.

11. Aerospace Medical Association. Medical oxygen and air travel. Aviat. Space Environ. Med. 2000; 71: 827–831.

12. Aerospace Medical Association. Inflight medical emergencies. Aviat. Space Environ. Med. 2000; 71: 832–838.

13. Air Transport Medicine Committee, Aerospace Medical Association. Medical guidelines for airline travel. Virginia: Aerospace Medical Association, 1997.

14. World Health Organisation. TB and air travel: guidelines for prevention and control. Geneva: WHO, 1998.

15. Joint Tuberculosis Committee of the British Thoracic Society. Control and prevention of tuberculosis in the United Kingdom: Code of Practice 2000. Thorax 2000; 55: 887–901.

16. Code of Federal Regulations. Title 14, part 25.841. Washington: US Government Printing Office, 1986.

17. Cottrell J.J. Altitude exposures during aircraft flight. Chest 1988; 92: 81–84.

18. Air Navigation Order. Schedule K, 1995.

19. Liebman J., Lucas R., Moss A. et al. Airline travel for children with chronic pulmonary disease. Pediatrics 1976; 57: 408–410.

20. Nunn J.F. Applied respiratory physiology. 3rd ed. London: Butterworths, 1987: 312.

21. Butland R.J., Pang J., Gross E.R. et al. Two, six, and 12 minute walking tests in respiratory disease. Br. Med. J. Clin. Res. Ed. 1982; 284: 1607–1608.

22. McGavin C.R., Gupta S.P., McHardy G.J. Twelve minute walking test for assessing disability in chronic bronchitis. Br. Med. J. 1976; 1: 822–823.

23. Revill S.M., Morgan M.D., Singh S.J. et al. The endurance shuttle walk: a new field test for the assessment of endurance capacity in chronic obstructive pulmonary disease. Thorax 1999; 54: 213–222.

24. Apte N.M., Karnad D.R. Altitude hypoxaemia and the arterial-to-alveolar oxygen ratio. Ann. Intern. Med. 1990; 112: 547–548.

25. Dillard T.A., Rosenberg A.P., Berg B.W. Hypoxaemia during altitude exposure. A meta-analysis of chronic obstructive pulmonary disease. Chest 1993; 103: 422–425.

26. Dillard T.A., Berg B.W., Rajagopal K.R. et al. Hypoxaemia during air travel in patients with COPD. Ann. Intern. Med. 1989; 111: 362–367.

27. Gong H., Tashkin D.P., Lee E.Y. et al. Hypoxia-altitude simulation test. Am. Rev. Respir. Dis. 1984; 130: 980–986.

28. Henry J.N., Krenis L.J., Cutting R.T. Hypoxaemia during aeromedical evacuation. Surg. Gynecol. Obstet. 1973; 136: 49–53.

29. Dillard T.A., Moores L.K., Bilello K.L. et al. The preflight evaluation. A comparison of the hypoxia inhalation test with hypobaric exposure. Chest 1995; 107: 352–357.

30. Cramer D., Ward S., Geddes D. Assessment of oxygen supplementation during air travel. Thorax 1996; 51: 202–203.

31. Vohra K.P., Klocke R.A. Detection and correction of hypoxemia associated with air travel. Am. Rev. Respir. Dis. 1993; 148: 1215–1219.

32. Lanteri C.J., Sly P.D. Changes in respiratory mechanics with age. J Appl Physiol 1993; 74: 369–378.

33. Greenough A. Neonatal pulmonary physiology. In: Rennie J.M., Roberton N.R.C., eds. Textbook of neonatology. 3rd ed. Edinburgh: Churchill Livingstone, 1999: 455–481.

34. Letsky E.A. Anaemia in the newborn. In: Rennie J.M., Roberton N.R.C., eds. Textbook of neonatology. 3rd ed. Edinburgh: Churchill Livingstone, 1999: 806–833.

35. Church N.R., Anas N.G., Hall C.B. et al. Respiratory syncytial virus-related apnea in infants. Demographics and outcome. Am. J. Dis. Child. 1984;.138:.247–250.

36. Bruhn F.W., Mokrohisky S.T., McIntosh K. Apnea associated with respiratory syncitial virus infection in young infants. J. Pediatr. 1977; 3: 382–386.

37. Buchdahl R.M., Babiker A., Bush A. et al. Predicting hypoxaemia during flights in children with cystic fibrosis. Thorax 2001; 56: 877–879.

38. Donaldson E., Pearn J. First aid in the air. Aust. NZ J. Surg. 1996; 66: 431–434.

39. Cottrell J.J., Callaghan J.T., Kohn G.M. et al. In-flight medical emergencies. One year of experience with the enhanced medical kit. J.A.M.A. 1989; 262: 1653–1656.

40. Poundstone W. Air travel and supplementary oxygen: friendly skies for respiratory patients? Respir. Ther. 1983; 13: 79–82.

41. Cates C.J. Holding chambers versus nebulisers for beta agonist treatment of acute asthma. (Cochrane Review). In: Cochrane Library. Issue 3. Oxford: Update Software, 1999.

42. Bonnet D., Marotel C., Miltgen J. et al. Travel and chronic respiratory insufficiency. Medecine Tropicale 1997; 57: 465–467.

43. Harinck E., Hutter P.A., Hoorntje T.M. et al. Air travel and adults with cyanotic congenital heart disease. Circulation 1996; 93: 272–276.

44. Dillard T.A., Beninati W.A., Berg B.W. Air travel in patients with chronic obstructive airways disease. Arch. Intern. Med. 1991; 151: 1793–1795.

45. Christensen C.C., Ryg M., Refvem O.K. et al. Development of severe hypoxaemia in chronic obstructive pulmonary disease patients at 2438 m (8000 ft) altitude. Eur. Respir. J. 2000; 15: 635–639.

46. Zaugg M., Kaplan V., Widemer U. et al. Fatal air embolism in an airplane passenger with a giant intrapulmonary bronchogenic cyst. Am. J. Respir. Crit. Care Med. 1998; 157: 1686–1689.

47. Domiciliary Oxygen Prescribing Services. Clinical guidelines and advice for prescribers. London: Royal College of Physicians, 1999.

48. Schwartz J.S., Bencowitz H.Z., Moser K.M. Air travel hypoxaemia with chronic obstructive pulmonary disease. Ann. Intern. Med. 1984; 100: 473–477.

49. Gong H.Jr. Air travel and oxygen therapy in cardiopulmonary patients. Chest 1992; 101: 1104–1113.

50. Graham W.G.B., Houston C.S. Short-term adaptation to moderate altitude. Patients with chronic obstructive pulmonary disease. J.A.M.A. 1978; 240: 1491–1494.

51. Berg B.W., Dillard T.A., Derderian S.S. et al. Haemodynamic effects of altitude exposure and oxygen administration in chronic obstructive pulmonary disease. Am. J. Med. 1993; 94: 407–412.

52. Oades P.J., Buchdahl R.M., Bush A. Prediction of hypoxaemia at high altitude in children with cystic fibrosis. Br. Med. J. 1994; 308: 15–18.

53. Driver C.R., Valway S.E., Morgan W.M. et al. Transmission of Mycobacterium tuberculosis associated with air travel. J.A.M.A. 1994; 272: 1031–1035.

54. McFarland J.W., Hickman C., Osterholm M.T. et al. Exposure to Mycobacterium tuberculosis during air travel. Lancet 1993; 342: 112–113.

55. Center for Disease Control and Prevention (CDC). Exposure of passengers and flight crew to Mycobacterium tuberculosis on commercial aircraft, 1992–1995. MMWR 1995; 44: 137–140.

56. Miller M.A., Valway S., Onorato I.M. Tuberculosis risk after exposure on airplanes. Tuberc. Lung Dis. 1996; 77: 414–419.

57. Kenyon T.A., Valway S.E., Ihle W.W. et al. Transmission of multidrug-resistant Mycobacterium tuberculosis during a long airplane flight. N. Engl. J. Med. 1996; 334: 933–938.

58. Moore M., Fleming K.S., Sands L. A passenger with pulmonary/laryngeal tuberculosis: no evidence of transmission on two short flights. Aviat. Space Environ. Med. 1996; 67: 1097–1100.

59. World Health Organisation. Tuberculosis and air travel: guidelines for prevention and control. Report WHO/TB/ 98.256. Geneva: WHO, 1998.

60. Moser M.R., Bender T.R., Margolis H.S. et al. An outbreak of influenza aboard a commercial airliner. Am. J. Epidemiol. 1979; 110: 1–6.

61. Amler R.W., Bloch A.B., Orenstein W.A. et al. Imported measles in the United States. J.A.M.A. 1982; 248: 2129–2133.

62. CDC. Epidemiological notes and reports. Interstate importation of measles following transmission in an airport, California, Washington 1982. MMWR 1983; 32: 210–216.

63. Richards P.R. The effects of air travel on passengers with cardiovascular and respiratory diseases. Practitioner 1973; 210: 2320–2341.

64. Noble J.S., Davidson J.A. Cor pulmonale presenting in a patient with congenital kyphoscoliosis following intercontinental air travel. Anaesthesia 1999; 54: 361–363.

65. Toff N.J. Hazards of air travel for the obese. Miss Pickwick and the Boeing 747. J. R. Coll. Physicians Lond. 1993; 27: 375–376.

66. Reite M., Jackson D., Cahoon R.L. et al. Sleep physiology at high altitude. Electroenceph. Clin. Neurophysiol. 1975; 38: 463–471.

67. Weil J.V., Kryger M.H., Scoggin C.H. Sleep and breathing at high altitude. In: Guilleminault C., Dement W.C., eds. Sleep apnea syndromes. New York: Alan R Liss, 1978: 119–136.

68. Powles A.C.P., Sutton J.R. Sleep at altitude. In: Seminars in respiratory medicine. Man at altitude. Volume 5. New York: Thieme-Stratton, 1983: 175–180.

69. Hackett P.H., Roach R.C., Harrison G.L. et al. Respiratory stimulants and sleep periodic breathing at high altitude. Am. Rev. Respir. Dis. 1987; 135: 896–898.

70. Nicholson A.N., Smith P.A., Stone B.M. et al. Altitude insomnia: studies during an expedition to the Himalayas. Sleep 1988; 11: 354–361.

71. Normand H., Barragan M., Benoit O. et al. Period breathing and O2 saturation in relation to sleep stages at high altitude. Aviat. Space Environ. Med. 1990; 61: 229–235.

72. Massard G., Thomas P., Wihlm J.M. Minimally invasive management for first and recurrent pneumothorax. Ann. Thorac. Surg. 1998; 66: 592–599.

73. Delaunois L., el Khawand C. Medical thoracoscopy in the management of pneumothorax. Monaldi Arch. Chest Dis. 1998; 53: 148–150.

74. Almind M., Lange P., Viskum K. Spontaneous pneumothorax: comparison of simple drainage, talc pleurodesis and tetracycline pleurodesis. Thorax 1989; 44: 627–630.

75. Liu H.P., Lin P.G., Hsieh M.G. et al. Thoracoscopic surgery as a routine procedure for spontaneous pneumothorax. Results from 82 patients. Chest 1995; 107: 559–562.

76. Olsen P.S., Andersen H.O. Long term results after tetracycline pleurodesis in spontaneous pneumothorax. Ann. Thorac. Surg. 1992; 53: 1015–1017.

77. Alfageme I., Moreno L., Huertas C. et al. Spontaneous pneumothorax. Long term results with tetracycline pleurodesis. Chest 1994; 106: 347–350.

78. Sadikot R.T., Greene T., Meadows K. et al. Recurrence of primary spontaneous pneumothorax. Thorax 1997; 52: 805–809.

79. Lippert H.L., Lund O., Blegvade S. et al. Independent risk factors for cumulative recurrence rate after first spontaneous pnemothorax. Eur. Respir. J. 1991; 4: 324–331.

80. Athanassiadi K., Kalavrouziotis G., Loutsidis A. et al. Surgical treatment of spontaneous pneumothorax: 10 year experience. World J. Surg. 1998; 22: 803–806.

81. Janssen J.P., Schramel F.M., Sutedja T.J. et al. Video thorascopic appearance of first and recurrent pneumothorax. Chest 1995; 108: 330–334.

82. British Thoracic Society Standards of Care Committee. Suspected acute pulmonary embolism: a practical approach. Thorax 1997; 52 (suppl. 4): S1–4.

83. Cruickshank J.M., Gorlin R., Jennett B. Air travel and thrombotic episodes: the economy class syndrome. Lancet 1988; ii: 497–498.

84. Paganin F., Laurent Y., Gauzers B.A. et al. Pulmonary embolism on non-stop flights between France and Reunion Island. Lancet 1996; 347: 1195–1196.

85. Symington I.S., Stack B.H.R. Pulmonary thromboembolism after travel. Br. J. Dis. Chest 1997; 71: 138–140.

86. Ledermann J.A., Keshavarzian A. Acute pulmonary embolism following air travel. Postgrad. Med. J. 1983; 59: 104–105.

87. Sahiar F., Mohler S.R. Economy class syndrome. Aviat. Space Environ. Med. 1994; 65: 957–960.

88. Milne R. Venous thromboembolism and travel: is there an association? J. R. Coll. Physicians Lond. 1992; 26: 47–49.

89. Mercer A., Brown J.D. Venous thromboembolism associated with air travel. A report of 33 patients. Aviat. Space Environ. Med. 1998; 69: 154–157.

90. Ferrari E., Chevalier T., Chapelier A. et al. Travel as a risk factor for venous thromboembolic disease: a case control study. Chest 1999; 115: 440–444.

91. House of Lords Select Committee on Science and Technology. Deep vein thrombosis, seating and stress. In: Air travel and health. Report of House of Lords Select Committee on Science and Technology, 2000: 44–50.

92. Forbes C.D., Johnston R.V. Venous and arterial thrombosis in airline passengers. J. R. Soc. Med. 1998; 91: 565–566.

93. Eklof B., Kistner R.L., Masuda E.M. et al. Venous thromboembolism in association with prolonged air travel. Dermatol. Surg. 1996; 22: 637–641.

94. Hyers T.M. Venous thromboembolism. Am. J. Respir. Crit. Care Med. 1999; 159: 1–14.

95. Scurr J.H., Machin S.J., Bailey)King S. et al. Frequency and prevention of symptomless deep-vein thrombosis in long haul flights: a randomised trial. Lancet 2001; 357: 1485–1489.

96. Pulmonary Embolism Prevention (PEP) Trial Collaborative Group. Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: pulmonary prevention (PEP) trial. Lancet 2000; 355: 1295–1302.

97. Vacanti J.J. Post-spinal headache and air travel. Anaesthesiology 1972; 37: 358–359.

98. Berg B.W., Dillard T.A., Rajagopal K.R. et al. Oxygen supplementation during air travel in patients with chronic obstructive lung disease. Chest 1992; 101: 638–641.

99. Byrne N.J. Comparison of airline oxygen systems. Aviat. Space Environ. Med. 1995; 66: 780–783.

100. Smeets F. Travel for technology dependent patients with respiratory disease. Thorax 1994; 49: 77–81.

101. Stoller J.K., Hoisington E., Auger G. A comparative analysis of arranging in-flight oxygen aboard commercial air carriers. Chest 1999; 115: 991–995.

102. Petrie G.J., Barnwell E., Grimshaw J., on behalf of the Scottish Intercollegiate Guidelines Network. Clinical guidelines: criteria for appraisal for national use. Edinburgh: Royal College of Physicians, 1995.

103. Agency for Health Care Policy and Research (AHCPR). Clinical practice guideline 92–0032. Rockville, Maryland: Agency for Healthcare Policy and Research Publications, 1992.

104. Agency for Health Care Policy and Rearch (AHCPR)/ Clinical practice guideline 92–0032. Rockville, Maryland: Agency for Healthcare Policy and Rearch Hublications, 1992.